July 6, 2025

An antibiotic developed in India has been identified as a game-changer in treating complicated urinary tract infections (UTIs) among Indian patients. Dr. V Balaji, a renowned clinical microbiology professor, highlighted the effectiveness of the antibiotic called cefepime-enmetazobactam at an international medical symposium in Pune. The antibiotic has shown promising results in treating complicated UTIs, with Dr. Balaji emphasizing its affordability and success. The symposium also addressed the issue of irrational use of antibiotics and the growing concern of antimicrobial resistance (AMR) in UTIs. Dr. Shirish Prayag, the organizing chairperson, shed light on the impact of AMR on global health and the need for newer treatment options. Dr. Kapil Zirpe, the organizing secretary, emphasized the importance of cautious antibiotic use and culture-based prescriptions. The symposium aimed to raise awareness about the rising challenges in UTI treatment and the significance of developing effective and affordable antibiotics to combat AMR.

Read More at News →

Tags: Antibiotic, India, Uti, Drug resistance, Symposium, Medical conference,